Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Legend Biotech (LEGN) Receivables - Net (2019 - 2025)

Legend Biotech filings provide 7 years of Receivables - Net readings, the most recent being $13.1 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 104.69% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.1 million, a 104.69% increase, with the full-year FY2025 number at $13.1 million, up 108.37% from a year prior.
  • Receivables - Net hit $13.1 million in Q4 2025 for Legend Biotech, up from $1.2 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $100.0 million in Q4 2023 to a low of $1967.0 in Q1 2021.
  • Median Receivables - Net over the past 5 years was $2.4 million (2021), compared with a mean of $15.7 million.
  • Biggest five-year swings in Receivables - Net: soared 2564770.36% in 2022 and later tumbled 99.89% in 2023.
  • Legend Biotech's Receivables - Net stood at $50.4 million in 2021, then plummeted by 99.82% to $90000.0 in 2022, then skyrocketed by 111056.67% to $100.0 million in 2023, then crashed by 93.6% to $6.4 million in 2024, then surged by 104.69% to $13.1 million in 2025.
  • The last three reported values for Receivables - Net were $13.1 million (Q4 2025), $1.2 million (Q3 2025), and $27.6 million (Q2 2025) per Business Quant data.